Items which should not routinely be prescribed in primary care: Summary of PCN statements PCN to PCN
|
|
- Mervyn Wells
- 5 years ago
- Views:
Transcription
1 Items which should not routinely be prescribed in primary care: Summary of PCN statements PCN to PCN In November 2017, NHS England issued final guidance in relation to items which should not routinely be prescribed in primary care. This guidance was considered by the PCN in January 2018 and policy statements developed. Group 1 Prescribers in primary care should not initiate for any new patient CCGS should support prescribers in deprescribing in all patients and, where appropriate, ensure the availability of relevant services to facilitate this change No routine exceptions have been identified Advice on switching given where appropriate PCN Herbal Treatments The Prescribing Clinical Network does not recommend the use of herbal treatments. Herbal treatments will be considered BLACK on the traffic light system and prescribers should NOT initiate herbal treatments in any new patients De-prescribe these treatments in all current patients, in line with NHS England guidance. PCN Homeopathy The Prescribing Clinical Network does not recommend the use of homeopathic items. Homeopathic items will be considered BLACK on the traffic light system and prescribers should NOT initiate homeopathic medications in any new patient De-prescribe homeopathic treatments in all current patients, in line with NHS England guidance. PCN Perindopril Arginine The Prescribing Clinical Network does not recommend the use of perindopril arginine. Perindopril arginine will be considered BLACK on the traffic light system and prescribers should: NOT initiate perindopril arginine in any new patients Switch any patients taking perindopril arginine to perindopril erbumine in line with NHS England guidance. 1
2 PCN Trimipramine The Prescribing Clinical Network does not recommend the use of trimipramine. Trimipramine will be considered BLACK on the traffic light system and prescribers should: NOT initiate trimipramine in any new patient Switch patients taking trimipramine to an alternative, more cost effective option, in line with NHS England guidance. PCN Co-Proxamol The Prescribing Clinical Network does not recommend the use of co-proxamol. Co-proxamol will be considered BLACK on the traffic light system. Prescribers should: NOT initiate co-proxamol for any new patient Switch patients taking co-proxamol to an alternative pain medication in line with NHS England guidance. PCN Prolonged-release The Prescribing Clinical Network does not recommend the use of prolonged-release doxazosin. Prolonged-release doxazosin will be considered BLACK on the traffic light system and prescribers Doxazosin (also should: known as Doxazosin NOT initiate prolonged release doxazosin for any new patient. Modified Release) For current patients - In reviewing prescribing of this drug, consider if doxazosin remains the best option for the therapeutic indication. If still indicated switch patients taking prolonged released doxazosin to immediate release doxazosin, in line with NHS England guidance. The Prescribing Clinical Network does not recommend the use of glucosamine and chondroitin. Glucosamine and chondroitin will be considered BLACK on the traffic light system and prescribers PCN PCN Glucosamine and chondroitin Lutein and antioxidants for the prevention of age related macular degeneration (AMD) should: NOT initiate glucosamine and chondroitin in any new patients De-prescribe glucosamine and chondroitin in all patients, in line with NHS England guidance. The Prescribing Clinical Network does not recommend the prescribing of lutein and antioxidants for the prevention of age related macular degeneration and they will be given a BLACK status on the traffic light system for this indication. Patients who are recommended to take these supplements can purchase these products over the counter from pharmacies. Prescribers should: NOT initiate lutein and antioxidants in any new patient De-prescribe lutein and antioxidants in current patients, in line with NHS England. 2
3 PCN PCN PCN Omega-3 Fatty Acid Compounds Paracetamol and Tramadol Combination Product Rubefacients (excluding topical NSAIDs) The Prescribing Clinical Network does not recommend the use of omega-3 fatty acid compounds for any indication other than for patients with raised triglycerides (on advice of a lipidologist). Omega-3 Fatty Acid Compounds will be considered BLACK on the traffic light system for all indications (except patients with raised triglycerides). Prescribers should: NOT initiate Omega 3 fatty acids compounds in any new patients; De-prescribe this treatment in all patients (other than patients with raised triglycerides), in line with NHS England guidance. The Prescribing Clinical Network does not recommend the use of paracetamol and tramadol combination product. Paracetamol and tramadol combination product will be considered BLACK on the traffic light system and prescribers should NOT initiate paracetamol and tramadol combination product for any new patient De-prescribe paracetamol and tramadol combination product with specialist support if appropriate, in all patients. The Prescribing Clinical Network does not recommend the use of rubefacients. Rubefacients will be considered BLACK on the traffic light system and prescribers should NOT initiate rubefacients for any new patient De-prescribe rubefacients in all patients in line with NHS England guidance. PCN Once Daily Tadalafil The Prescribing Clinical Network does not recommend the use of once daily tadalafil. Once daily tadalafil will be considered BLACK on the traffic light system and prescribers should NOT initiate once daily tadalafil in any new patient De-prescribe once-daily tadalafil in all patients in line with NHS England guidance. 3
4 Group 2 Prescribers in primary care should not initiate for any new patient CCGs should support prescribers in deprescribing in all patients and, where appropriate, ensure the availability of relevant services to facilitate this change In exceptional circumstances there may be a clinical need for the drug to be prescribed then this should be undertaken in a cooperation arrangement with a multi-disciplinary team and/or other healthcare professional No routine exceptions have been identified PCN Dosulepin The Prescribing Clinical Network does not recommend the use of dosulepin. Dosulepin will be considered BLACK on the traffic light system, prescribers should: NOT initiate dosulepin for any new patient Switch patients taking dosulepin to an alternative antidepressant In exceptional circumstances where there is a clinical need for dosulepin to be prescribed in primary care this should be undertaken in a cooperation arrangement with a multidisciplinary team and / or other healthcare professional. PCN Oxycodone and Naloxone Combination Product (Targinact) The Prescribing Clinical Network does not recommend the use of oxycodone and naloxone combination product. Oxycodone and Naloxone Combination Product will be considered BLACK on the traffic light system, prescribers should: NOT initiate oxycodone and naloxone combination product for any new patient De-prescribe oxycodone and naloxone combination product, with specialist support if appropriate, in all patients. In exceptional circumstances where there is a clinical need for oxycodone and naloxone combination product to be prescribed in primary care this should be undertaken in a cooperation arrangement with a multidisciplinary team and / or other healthcare professional. 4
5 Group 3 Prescribers in primary care should not initiate for any new patient CCGs should support prescribers in deprescribing in all patients and, where appropriate, ensure the availability of relevant services to facilitate this change In exceptional circumstances there may be a clinical need for the drug to be prescribed then this should be undertaken in a cooperation arrangement with a multi-disciplinary team and/or other healthcare professional Exceptions and further recommendations are included PCN Immediate Release Fentanyl for all indications other than palliative care treatment in line with NICE CG140 Immediate Release Fentanyl will be considered BLACK on the traffic light system for all indications other than palliative care treatment in line with NICE CG140. The PCN does not recommend the use of Immediate Release Fentanyl other than for patients undergoing palliative care treatment and where the recommendation to use immediate release fentanyl in line with NICE CG140 (opioids in palliative care) has been made by a multi-disciplinary team and / or other healthcare professional with a recognised specialism in palliative care. Prescribers should: NOT initiate immediate release fentanyl for any new patient Switch patients taking immediate release fentanyl to an alternative, with specialist support, in line with NHS England guidance (excluding palliative care in line with NICE CG140. In exceptional circumstances, if there is a clinical need for immediate release fentanyl to be prescribed in primary care this should be undertaken in a cooperation arrangement with a multidisciplinary team and / or other healthcare professional. 5
6 PCN Lidocaine Plasters for all indications other than use for the licensed indication (symptomatic relief of neuropathic pain associated with previous herpes zoster infection) in line with NICE CG173 The Prescribing Clinical Network does not recommend the unlicensed use of lidocaine plasters. Lidocaine plasters will be considered BLACK on the traffic light system for all unlicensed uses, primary care prescribers should NOT initiate lidocaine plasters for any new patient De-prescribe lidocaine plasters in all patients with specialist support if appropriate, in line with NHS England guidance In exceptional circumstances there may be a clinical need for lidocaine plasters to be prescribed in primary care. The specialists and the prescriber will need to have informed discussions about prescribing these medicines for individual patients. PCN Travel vaccines (Hepatitis B, Japanese Encephalitis, Meningitis ACWY, Yellow Fever, Tickborne encephalitis, rabies & BCG) exclusively for the purposes of travel Liothyronine (Armour Thyroid and liothyronine combination products) The Prescribing Clinical Network considers that Hepatitis B, Japanese Encephalitis, Meningitis ACWY, Yellow Fever, Tick-borne encephalitis, rabies & BCG vaccines should not be given on the NHS exclusively for the purpose of travel for any new patient. The vaccines may continue to be administered for purposes other than travel, if clinically appropriate. Hepatitis B, Japanese Encephalitis, Meningitis ACWY, Yellow Fever, Tick-borne encephalitis, rabies & BCG vaccines will be considered BLACK on the traffic light system exclusively for the purpose of travel for any new patient. New Policy statement is not required as individual indications for liothryonine already have policy statements on the PAD. Note that there is a requirement for patients currently taking liothyronine to be reviewed by specialists. 6
CONSULATION ON ITEMS WHICH SHOULD NOT BE ROUTINELY PRESCRIBED IN PRIMARY CARE FREQUENTLY ASKED QUESTIONS
CONSULATION ON ITEMS WHICH SHOULD NOT BE ROUTINELY PRESCRIBED IN PRIMARY CARE FREQUENTLY ASKED QUESTIONS Consultation content: 18 products Patient experience Savings Working group Over-the-counter medicines
More informationItems which should not routinely be prescribed in primary care: A Consultation on guidance for CCGs
Items which should not routinely be prescribed in primary care: A Consultation on guidance for CCGs Items which should not routinely be prescribed in primary care: A Consultation on guidance for CCGs Version
More informationNovember 2018 Review date: November 2020
November 2018 Review date: November 2020 Executive Summary 3 Introduction 4 Background 4 Scope 5 Resources to implement this policy 6 Policy review 6 Table of items with formulary indication 7 Co-proxamol
More informationPlease select which items you would like to share your views on (please select)? NHS England proposes to advise clinical commissioning groups,
Items which should not routinely be prescribed in primary care: A Consultation on guidance for CCGs Homeopathy Research Institute submission to public consultation by NHS England 21 October 2017 Rachel
More informationItems which should not be routinely prescribed in primary care: Consultation Report of Findings NHS England
Items which should not be routinely prescribed in primary care: Consultation Report of Findings NHS England NHS England INFORMATION READER BOX Directorate Medical Operations and Information Specialised
More informationNHS ENGLAND BOARD PAPER
NHS ENGLAND BOARD PAPER Paper: PB.21.07.2017/05 Title: Items which should not routinely be prescribed in primary care Lead Director: Professor Sir Bruce Keogh, Medical Director Paul Baumann, Chief Financial
More informationNATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE
NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE 1 Guideline title SCOPE Neuropathic pain pharmacological management: the pharmacological management of neuropathic pain in adults in non-specialist
More informationBerkshire West Area Prescribing Committee Guidance
Guideline Name Berkshire West Area Prescribing Committee Guidance Date of Issue: September 2015 Review Date: September 2017 Date taken to APC: 2 nd September 2015 Date Ratified by GP MOC: Guidelines for
More informationGuidelines for the Management of Chronic Non-Malignant Pain (CNMP) in Primary Care (not including neuropathic pain (NeP).
Surrey (East Surrey CCG, Guildford & Waverley CCG, North West Surrey CCG, Surrey Downs CCG & Surrey Heath CCG) North East Hampshire & Farnham CCG and Crawley, Horsham & Mid-Sussex CCG Guidelines for the
More informationProposed changes to prescribing in Croydon. Lambeth. NHS prescriptions in Lambeth
Proposed changes to prescribing in Croydon Lambeth NHS prescriptions in Lambeth 1 NHS Lambeth Clinical Commissioning Group 1. Introduction We are seeking your views on our proposals to make some changes
More informationMeeting of the South and West Devon Formulary Interface Group Minutes
Meeting of the South and West Devon Interface Group Minutes Wednesday 17 th January 2018: 2:00 pm 4.30 pm The Watermark, Erme Court, Leonards Road, Ivybridge PL21 0SZ Present: Chris Roome (Chair) Head
More informationGUIDANCE ON PRESCRIBING VACCINATIONS ON THE NHS & PRIVATELY (INCLUDING TRAVEL VACCINATIONS)
GUIDANCE ON PRESCRIBING VACCINATIONS ON THE NHS & PRIVATELY (INCLUDING TRAVEL VACCINATIONS) Under the new GMS contract (from 2004), vaccinations and immunisations are paid for through various mechanisms
More informationProposed changes to prescribing in Croydon MALARIA TABLETS. Consultation on proposed changes to NHS prescriptions in Southwark
Proposed changes to prescribing in Croydon MALARIA TABLETS Consultation on proposed changes to NHS prescriptions in Southwark NHS Croydon Clinical Commissioning Group Contents Who are we and what is this
More informationStaff Immunisation Policy
Policy No: IC05 Version: 8.0 Name of Policy: Staff Immunisation Policy Effective From: 18/08/2015 Date Ratified 15/07/2015 Ratified Infection Prevention & Control Committee Review Date 01/07/2017 Sponsor
More informationrequesting information regarding Referral target schemes for GPs in NHS Ashford Clinical Commissioning Group
August 2015 Our Ref: FOI.15.ASH0102 requesting information regarding Referral target schemes for GPs in NHS Ashford Clinical Commissioning Group a) Does the CCG currently operate any schemes for GPs which
More informationrequesting information regarding Rebate and QIPP prescribing schemes in NHS Canterbury and Coastal Clinical Commissioning Group
July 2015 Our Ref: FOI.15.CAN0059 requesting information regarding Rebate and QIPP prescribing schemes in NHS Canterbury and Coastal Clinical Commissioning Group Could you please provide me with the details
More informationPromotion of Self Care Briefing Document
RCCG/GB/17/035 Promotion of Self Care Briefing Document 1. Introduction The proposal aims to promote self-care through the purchasing of medications and products from local pharmacies for the treatment
More informationSwitching Tramacet to paracetamol alone or paracetamol and codeine
Bulletin 62 February 2014 Community Interest Company Switching Tramacet to paracetamol alone or paracetamol and codeine This is one of a number of bulletins providing further information on medicines contained
More informationUSE OF UNLICENSED MEDICINES AND OFF-LABEL MEDICINES WHERE A LICENSED MEDICINE IS AVAILABLE
NHS Scotland Directors of Pharmacy and Scottish Association of Medical Directors USE OF UNLICENSED MEDICINES AND OFF-LABEL MEDICINES WHERE A LICENSED MEDICINE IS AVAILABLE CONSENSUS STATEMENT This consensus
More information1 e f forte.uk.com t January 2018
t 0370 241 8717 e info@forte.uk.com f 01622 790 754 forte.uk.com January 2018 In July 2017, the NHS England Board approved consultation on a set of proposals to limit the primary care prescribing of 18
More informationFamily and Travel Vaccinations
Family and Travel Vaccinations We offer the full range of baby, child and family vaccinations. We are able to tailor schedules to your child s needs or international schedule. We have a suggested vaccination
More information7 th November % of patients had lidocaine plasters prescribed for the licensed indication of post herpatic neuralgia
Directorate of Integrated Care Health and Social Care Board 12-22 Linenhall Street Belfast BT2 8BS Tel : 028 90553782 Fax : 028 90553622 Web Site: www.hscboard.hscni.net 7 th November 2013 Dear colleague
More informationThey are updated regularly as new NICE guidance is published. To view the latest version of this NICE Pathway see:
bring together everything NICE says on a topic in an interactive flowchart. are interactive and designed to be used online. They are updated regularly as new NICE guidance is published. To view the latest
More informationChief Dental Officer England: Advice on commercial practice of online registered dental practitioners selling patient group directions for NHS
Chief Dental Officer England: Advice on commercial practice of online registered dental practitioners selling patient group directions for NHS England commissioned services. Chief Dental Officer England:
More informationGuidelines for the Pharmacological Management of Chronic Pain in Primary Care. December 2012
Guidelines for the Pharmacological Management of Chronic Pain in Primary Care December 2012 NHS Portsmouth CCG Fareham and Gosport CCG South Eastern Hampshire CCG 1 Guidelines for the Pharmacological Management
More informationRituximab treatment in autoimmune blistering diseases
Rituximab treatment in autoimmune blistering diseases This leaflet explains more about having treatment with the medicine rituximab for an autoimmune blistering disease. It includes information about the
More informationSpecialist Palliative Care Audit and Guidelines Group (SPAGG)
Specialist Palliative Care Audit and Guidelines Group (SPAGG) Clinical Guideline for the Prescribing and Administration of Furosemide via continuous subcutaneous infusion (CSCI) for Heart Failure Patients
More informationSuffolk PCT Drug & Therapeutics Committee New Medicine Report (Adopted by the CCG until review and further notice)
Suffolk PCT Drug & Therapeutics Committee New Medicine Report (Adopted by the CCG until review and further notice) This drug has been reviewed because it is a product that may be prescribed in primary
More informationThey are updated regularly as new NICE guidance is published. To view the latest version of this NICE Pathway see:
bring together everything NICE says on a topic in an interactive flowchart. are interactive and designed to be used online. They are updated regularly as new NICE guidance is published. To view the latest
More informationtablet/capsule Paracetamol 500mg
Formulary Item Restrictions and/or Advice Non-opioid analgesics + compound analgesic preparations Aspirin 75mg dispersible Aspirin 300mg dispersible Aspirin 300mg Aspirin 75mg EC Paracetamol 500mg / Paracetamol
More informationPlacename CCG. Policies for the Commissioning of Healthcare. Policy for Managing Back Pain- Spinal Injections
Placename CCG Policies for the Commissioning of Healthcare Policy for Managing Back Pain- Spinal Injections 1 Introduction 1.1 This document is part of a suite of policies that the CCG uses to drive its
More informationMid Essex Locality Guideline for Management of Adult Acute and Chronic Non-Cancer Pain in Primary care
Guideline for Management of Adult Acute and Chronic Non-Cancer Pain in Primary care If possible patients should be assessed using a simple visual analogue scale VAS to determine the most appropriate stage
More informationPain Management Documents
Pain Management Documents Prescriber and Patient Resources Non-cancer Pain Guidance Neuropathic Pain Guidance Stopping or Switching low strength Buprenorphine Patches Red and Yellow Flags Medicines Management
More informationGUIDELINES AND AUDIT IMPLEMENTATION NETWORK
GUIDELINES AND AUDIT IMPLEMENTATION NETWORK General Palliative Care Guidelines The Management of Pain at the End Of Life November 2010 Aim To provide a user friendly, evidence based guide for the management
More informationCanadian Chiropractic Guideline Initiative (CCGI) Guideline Summary
Canadian Chiropractic Guideline Initiative (CCGI) Guideline Summary Title of guideline Osteoarthritis: care and management Clinical guideline Author of guideline National Institute for Health and Care
More informationPersistent Pain Resources. Educational Slide Set
Persistent Pain Resources Educational Slide Set October 216 This document has been prepared by a multiprofessional collaborative group, with support from the All Wales Prescribing Advisory Group (AWPAG)
More informationCare homes - Homely remedies
Bulletin 72 August 2014 Care homes - Homely remedies Care home staff have a recognised duty of care to be able to respond to minor symptoms experienced by residents. A homely remedy is a medicinal product
More informationGUIDELINES ON THE MANAGEMENT OF PAIN DUE TO CANCER IN ADULTS
GUIDELINES ON THE MANAGEMENT OF PAIN DUE TO CANCER IN ADULTS Bristol Palliative Care Collaborative Contact Numbers: Hospital Specialist Palliative Care Teams: North Bristol 0117 4146392 UH Bristol 0117
More informationGuideline scope Persistent pain: assessment and management
National Institute for Health and Clinical Excellence [document type for example, IFP, QRG] on [topic] Document cover sheet Date Version number Editor 30/08/2017 1 NGC Action 1 2 3 4 5 6 7 8 9 10 11 12
More informationMethotrexate for inflammatory bowel disease: what you need to know
Methotrexate for inflammatory bowel disease: what you need to know This leaflet aims to answer your questions about taking methotrexate for inflammatory bowel disease (IBD). If you have any questions or
More informationNeuropathic Pain Treatment Guidelines
Neuropathic Pain Treatment Guidelines Background Pain is an unpleasant sensory and emotional experience that can have a significant impact on a person s quality of life, general health, psychological health,
More informationThank you for offering the opportunity to comment on the proposed amendments to the Pharmacy Act (Proposal #16-HLTC005).
Administration & Office of the Medical Officer of Health Telephone: 519-383-8331 160 Exmouth Street Toll-free: 1-800-667-1839 Point Edward, ON N7T 7Z6 Fax: 519-383-7092 www.lambtonhealth.on.ca Ontario
More informationGuidance - Prescribing of Liothyronine
Guidance - Prescribing of Liothyronine Regional Medicines Optimisation Committee (RMOC) November 2018 Version 2.0 Document Control Document location Copies of this document can be obtained from https://www.sps.nhs.uk/
More informationImmunizations for Children and Teens with Suppressed Immune Systems
Immunizations for Children and Teens with Suppressed Immune Systems Your child is starting treatment that will suppress the immune system. This will affect how your child s body responds to routine immunizations
More informationNHS West Cheshire Clinical Commissioning Group does not fund the prescribing for dental conditions on FP10.
PRESCRIBING COMMISSIONING POLICY: DENTAL CONDITIONS NHS West Cheshire Clinical Commissioning Group does not fund the prescribing for dental conditions on FP10. Note: Patients who are not eligible for treatment
More informationTramadol Educational Resource Materials. Educational Slide Set
Tramadol Educational Resource Materials Educational Slide Set November 2013 These educational resource materials have been prepared by a multiprofessional collaborative group, with support from the All
More informationUNIVERSITY OF UTAH INTERNATIONAL TRAVEL CLINIC Phone: Fax: N Medical Dr. Salt Lake City, UT 84132
Welcome to UNIVERSITY OF UTAH INTERNATIONAL TRAVEL CLINIC Phone: 801-801-581-2898 Fax: 801-585-7315 50 N Medical Dr. Salt Lake City, UT 84132 Our goal is to help you have a safe and enjoyable experience
More informationNATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE
NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE 1 Guideline title SCOPE Chronic obstructive pulmonary disease: the management of adults with chronic obstructive pulmonary disease in primary and secondary
More informationWorld Bank Group Medical Benefits Plan (MBP) A Guide to Preventive Care Effective 2015
World Bank Group Medical Benefits Plan (MBP) A Guide to Preventive Care Effective The Bank Group s Medical Benefits Plan (MBP), Continuation Medical Benefits Plan (CMBP) and Retiree Medical Benefits Plan
More informationUsing strong opiods for pain in palliative care
Using strong opiods for pain in palliative care What are strong opioids? They are strong medicines used to control pain when weaker painkillers have not been effective. (They can also sometimes be used
More informationScottish Medicines Consortium
Scottish Medicines Consortium duloxetine 30mg and 60mg capsules (Cymbalta ) No. (285/06) Eli Lilly and Company Limited/Boehringer Ingelheim 4 August 2006 The Scottish Medicines Consortium has completed
More informationThe NICE revised guidelines for the management of non-specific low back pain and; Implications for Practice
The NICE revised guidelines for the management of non-specific low back pain and; Implications for Practice David Walsh David.walsh@nottingham.ac.uk National Clinical Guideline Centre Commissioned by NICE
More informationSCHEDULE 2 THE SERVICES
SCHEDULE 2 THE SERVICES A. Service Specifications Mandatory headings 1 4: mandatory but detail for local determination and agreement Optional headings 5-7: optional to use, detail for local determination
More informationResource impact report: Sofosbuvir velpatasvir for treating chronic hepatitis C TA430
Putting NICE guidance into practice Resource impact report: Sofosbuvir velpatasvir for treating chronic hepatitis C TA430 Published: January 2017 Summary Sofosbuvir velpatasvir is recommended as an option
More informationSubstance use and misuse
An open learning programme for pharmacists and pharmacy technicians Substance use and misuse Educational solutions for the NHS pharmacy workforce DLP 160 Contents iii About CPPE open learning programmes
More informationRecommendations from the Devon Prisons Health Needs Assessment. HMP Exeter, HMP Channings Wood and HMP Dartmoor
from the Devon Prisons Health Needs Assessment HMP Exeter, HMP Channings Wood and HMP Dartmoor 2011-2012 In April 2006 the responsibility for prison healthcare transferred from HM Prison Service to the
More informationCONJUGATE MENINGOCOCCAL (ACWY) VACCINE
Cumbria & Lancashire Vaccine PGD Group ADVISORY INFORMATION FOR USE WITH PATIENT SPECIFIC DIRECTION OR INDIVIDUAL PRESCRIPTION SIGNED BY GP OR NON-MEDICAL PRESCRIBER. CONJUGATE MENINGOCOCCAL (ACWY) VACCINE
More informationChildren s palliative care is defined as an active and total approach to care, from the point of diagnosis or recognition, throughout the child s
Level : a consultant paediatrician in PPM, or a small number of children s hospice medical leaders (mainly leaders in sub-specialty formation and development, and with roles beyond their local hospice),
More informationTHE EAPC OPIOID GUIDELINES: PROCESS, RESULTS AND FUTURE DEVELOPMENT
1 THE EAPC OPIOID GUIDELINES: PROCESS, RESULTS AND FUTURE DEVELOPMENT Jaegtvolden 4-5 June 2012 14. 12. 2012 2 1 3 WHO ANALGESIC LADDER (1996) NSAID +/- Adjuvant STEP II OPIODS Opids for mild to moderate
More informationLow back pain and sciatica in over 16s NICE quality standard
March 2017 Low back pain and sciatica in over 16s NICE quality standard Draft for consultation This quality standard covers the assessment and management of non-specific low back pain and sciatica in young
More informationAdult Neurodevelopmental Services. ADHD Shared Protocol
Adult Neurodevelopmental Services ADHD Shared Protocol Issue 1: April 2016 1 2 Adult Neurodevelopmental Service Shared Care Protocol for Adult Attention Deficit Hyperactivity Disorder (ADHD) 1. BACKGROUND
More informationPRIMARY MANAGEMENT OF DRUG PRESCRIBING IN NON-MALIGNANT PAIN
NORTH OF TYNE GUIDELINES FOR: PRIMARY MANAGEMENT OF DRUG PRESCRIBING IN NON-MALIGNANT PAIN (EXCLUDING DETAILED RECOMMENDATIONS FOR LONG TERM STRONG OPIATES) February 2015 (minor update April 2017) 1 CONTENTS
More informationFORMULARY UPDATES ABUHB s Drug Formulary is at:
Aneurin Bevan University Health Board Medicines & Therapeutics Committee PRESCRIBING enewsletter archive at: http://www.wales.nhs.uk/sites3/page.cfm?orgid=814&pid=48407 Dear Gwent Prescriber At its last
More informationQ&A: Opioid Prescribing for Chronic Non-Malignant Pain
NHS Hastings and Rother Clinical Commissioning Group Chair Dr David Warden Chief Officer Amanda Philpott NHS Eastbourne, Hailsham and Seaford Clinical Commissioning Group Chair Dr Martin Writer Chief Officer
More informationIntroduction. Infections acquired by travellers
Introduction The number of Australians who travel overseas has increased steadily over recent years and now between 3.5 and 4.5 million exits are made annually. Although many of these trips are to countries
More informationSummary of Main Points from the Meeting held on Monday 9 th April 2018
Summary of Main Points from the Meeting held on Monday 9 th April 2018 2. Minutes and Summary Notes from last meeting The Minutes and Summary notes from the 12 th March 2018 Medicines Group meeting were
More informationPain management following your operation
INFORMATION FOR PATIENTS Pain management following your operation Following your operation we want you to be as comfortable as possible. While we cannot guarantee you will be absolutely pain-free, painkillers
More informationAdministration of Tuberculin Purified Protein Derivative (PPD) 2TU per 0.1ml to patients attending BCG clinics with identified TB at risk factors.
Administration of Tuberculin Purified Protein Derivative (PPD) 2TU per 0.1ml to patients attending BCG clinics with identified TB at risk factors. Special notes PPD is an unlicensed medicine and therefore
More informationWhat are the new active vaccine recommendations in the Canadian Immunization Guide?
154 CCDR 17 April 2014 Volume 40-8 https://doi.org/10.14745/ccdr.v40i08a03 1 What are the new active vaccine recommendations in the Canadian Immunization Guide? Warshawsky B 1 and Gemmill I 2 on behalf
More informationPassport Tickets Travel Insurance TRAVEL HEALTH?
Passport Tickets Travel Insurance TRAVEL HEALTH? Over 70 million trips abroad are made from the UK every year 1, but around 50% of travellers seek no health advice before travelling 2. This means many
More informationShould Not Prescribe List
a Alendronate plus Vitamin D (Fosavance ) Separate components more cost effective Fosavance 22.80 for 4 tablets vs Alendronate 70mg tabs 0.96 Ammonium Chloride preparations e.g. DriChlor, Anhydrol Forte,
More informationGood Practice Guidance on Covert Administration of Medication
Good Practice Guidance on Covert Administration of Medication This good practice guidance is intended to be used as a framework for care home managers and domiciliary care providers in drawing up their
More informationOur Mission. To promote healthy and safe travel by providing medicines, preventive vaccines and health counseling to a diverse group of travelers
Our Mission To promote healthy and safe travel by providing medicines, preventive vaccines and health counseling to a diverse group of travelers The Travel Clinic utilizes national and international travel
More informationPrimary care review of Tramadol Prescribing
Primary care review of Tramadol Prescribing Aim of the Audit To ensure the prescribing of tramadol is safe, appropriate and regularly reviewed, in line with local chronic pain guidelines 1 Background Tramadol
More informationCare homes - Homely remedies
Bulletin 72 August 2014 Community Interest Company Care homes - Homely remedies Care home staff have a recognised duty of care to be able to respond to minor symptoms experienced by residents. A homely
More informationAnalgesics: Management of Pain In the Elderly Handout Package
Analgesics: Management of Pain In the Elderly Handout Package Analgesics: Management of Pain in the Elderly Each patient or resident and their pain problem is unique. A complete assessment should be performed
More informationAnalgesia in patients with impaired renal function Formulary Guidance
Analgesia in patients with impaired renal function Formulary Guidance Approved by Trust D&TC: January 2010 Revised March 2017 Contents Paragraph Page 1 Aim 4 2 Introduction 4 3 Assessment of renal function
More informationPain management in palliative care. Dr. Stepanie Lippett and Sister Karen Davies-Linihan
Pain management in palliative care Dr. Stepanie Lippett and Sister Karen Davies-Linihan contents Concept of total pain Steps in pain management Recognising neuropathic pain WHO analgesic ladder Common
More informationRELEVANT ACUTE TRUST LOGO WORKING IN PARTNERSHIP WITH
RELEVANT ACUTE TRUST LOGO WORKING IN PARTNERSHIP WITH Surrey (East Surrey CCG, Guildford & Waverley CCG, North West Surrey CCG, Surrey Downs CCG & Surrey Heath) North East Hampshire & Farnham CCG, Crawley
More informationService Level Agreement for the Provision of Level 1 Substance Misuse Services from a Community Pharmacy under contract to NHS Grampian
Service Level Agreement for the Provision of Level 1 Substance Misuse Services from a Community Pharmacy under contract to NHS Grampian 1. Introduction The provision of Substance Misuse (SM) services through
More informationRisk Consultation and Assessment
Risk Consultation and Assessment Please find product Prescribing Information at the end of this presentation UK/VAC/0047/16b Date of preparation: July 2016 The pre-travel risk consultation When to do it?
More informationPrescribing Dilemmas. Sue Mulvenna Head of Pharmacy and CD Accountable Officer South Region SW 19 th May
Prescribing Dilemmas Sue Mulvenna Head of Pharmacy and CD Accountable Officer South Region SW 19 th May 2016 The four principles of medicines optimisation Aim to understand the patient s experience Evidence
More informationPRIMARY CARE BRIEFING GLUSARTEL (GLUCOSAMINE SULPHATE)
Summary This Primary Care Briefing informs healthcare professionals of a new preparation of glucosamine sulphate, Glusartel, licensed for the relief of symptoms in mild to moderate osteoarthritis of the
More informationDrugs used for the treatment of pain Simple Analgesics Weak Opioids Strong Opioids Oral Strong Opioids Transdermal Strong Opioids Subcutaneous
Drugs used for the treatment of Simple Analgesics Weak Opioids Strong Opioids Oral Strong Opioids Transdermal Strong Opioids Subcutaneous Adjuvant analgesics Non Steroidal Anti-Inflammatory Drugs (NSAIDs)
More informationCarrying out a structured medication review
n MEDICINES OPTIMISATION Carrying out a structured medication review SHARON COANE and ROSALYNE PAYNE As part of our series on the NICE guideline on Medicines Optimisation, Sharon Coane and Rosalyne Payne
More informationCover images courtesy of jk1991 at FreeDigitalPhotos.net Infographics courtesy of SIMPATHY consortium
If using any content from this document, please acknowledge the Scottish Government Polypharmacy Model of Care Group, 2018. When referencing this document, please use the following format: Scottish Government
More informationPalliative Prescribing - Pain
Palliative Prescribing - Pain LAURA BARNFIELD 21/2/17 Aims To understand the classes of painkillers available in palliative care To gain confidence in counselling regarding opiates To gain confidence prescribing
More informationPolicy on Pharmacological Therapies Practice Guidance Note Reducing Dosing Errors with Opioid Medicines V04
Policy on Pharmacological Therapies Practice Guidance Note Reducing Dosing Errors with Opioid Medicines V04 Date issued Issue 1 Nov 2018 Planned review Nov 2021 PPT-PGN 18 part of NTW(C)38 Pharmaceutical
More informationHomely Remedies Guidance for Care Homes
Homely Remedies Guidance for Care Homes What is a homely remedy? Homely or household remedy is another name for a non-prescription medicine which is used in a care home for the short term management of
More information2017/18 Immunisation programmes list of additional and enhanced services
2017/18 Immunisation programmes list of additional and enhanced services 2017/18 Vaccination and Immunisation list of additional and enhanced services Version number: 1 First published: April 2017 Prepared
More informationNew NICE guideline updates recommendations for diagnosing latent tuberculosis
Tel: 0845 003 7782 www.nice.org.uk Ref: 2011/053 PRESS RELEASE New NICE guideline updates recommendations for diagnosing latent tuberculosis The National Institute for Health and Clinical Excellence (NICE)
More informationAshtead Hospital. Private GP Services. Ashtead Hospital
Ashtead Hospital Private GP Services Ashtead Hospital Private GP appointments at a time to suit you It is our commitment to practice modern medicine with traditional values. At the heart of our service
More information2018/19 Immunisation programmes list of additional and enhanced services
2018/19 Immunisation programmes list of additional and enhanced services 2018/19 Vaccination and Immunisation list of additional and enhanced services Version number: 1 First published: April 2018 Prepared
More informationProton Pump Inhibitor De-prescribing Guidance
Amendment History Proton Pump Inhibitor De-prescribing Guidance VERSION DATE AMENDMENT HISTORY 1.0 2013 Previous version 2.0 September 2015 Comments Amendment to Flow chart and addition of Rationale page
More informationStrong opioids for palliative care patients
Other formats Strong opioids for palliative care patients If you need this information in another format such as audio tape or computer disk, Braille, large print, high contrast, British Sign Language
More informationGuideline scope Diverticular disease: diagnosis and management
NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE Guideline scope Diverticular disease: diagnosis and management The Department of Health in England has asked NICE to develop a clinical guideline on diverticular
More informationCare Homes - Homely Remedies Protocol
Care Homes - Homely Remedies Protocol A homely remedy is a medicine for the short-term treatment of a minor ailment, such as indigestion, a cough, mild to moderate pain or constipation, and can be obtained
More informationNICE update. Paul Chrisp, Programme Director, Medicines and Prescribing Centre
NICE update Paul Chrisp, Programme Director, Medicines and Prescribing Centre Outline NICE offers a comprehensive suite of guidance, advice and support for delivering quality, safety and efficiency in
More informationSmoking Cessation and Pharmacy Care Record (PCR)
1 Smoking Cessation and Pharmacy Care Record (PCR) Before starting a new assessment check the following: Does the patient consent to Follow Up? If No, do not proceed as it is no longer permitted under
More information